Regencell Bioscience Holdings Limited

Fundamentals1.0
Price Action4.0
News Sentiment3.0
AI Rating
2.0

Key Drivers

  • Liquidity erosion
  • Deep losses
  • Shrinking equity

AI
AI Summary

2.0

RGC should be viewed as a high-risk financing and credibility story rather than an early-stage growth play, because it still has no revenue, persistent losses, shrinking equity, and a serious legal/regulatory overhang, so the recent price bounce is not a fundamental validation and dilution or further balance-sheet stress remains the key risk.

Legal
Dilution
CashBurn

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

1.0

Key Financial Insights:

  • Liquidity erosion
  • Deep losses
  • Shrinking equity

RGC has low debt and still holds cash, but rapidly weakening liquidity, no revenue, persistent losses, shrinking equity, and an extreme valuation make the investment case highly fragile.

fragile
overvalued

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Support Holding
  • Failed Breakouts
  • Volatile Swings

RGC has bounced off the $5.00 support and improved short term, but repeated failures in the mid-$5s to low-$6s keep the trend bearish until resistance is cleared.

RGC
bearish
Support Level: $5.00
Resistance Level: mid-$5s to low-$6s

Sharp, short-lived rallies and abrupt swings suggest unstable price action

Sentiment & News

3.0

Key News Insights:

  • Rate-driven margins
  • Expense pressure
  • Customer loss

RGC Resources' Q3 earnings were essentially flat as higher rate-driven margins offset by higher expenses, weather swings, and a lost industrial customer.

earnings
utilities

The results suggest limited near-term upside for the stock as regulatory benefits are being offset by operational and demand headwinds